Groussin L, Theodon H, Bessiene L, Bricaire L, et al. Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer. Thyroid 2022 Feb 16. doi: 10.1089/thy.2021.0524.
PMID: 35171708